Gene · 5158
Papers1,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,506
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiparameter immunoprofiling for the diagnosis and differentiation of progressive versus nonprogressive nontuberculous mycobacterial lung disease-A pilot study. | PLoS One | 2024 | 38640113 | PubTator, text mining | PubMed |
| Open-Angle and Steroid-Induced Glaucoma in Patients With Retinitis Pigmentosa: A Dangerous Liaison. | Cureus | 2024 | 38586746 | PubTator, text mining | PubMed |
| Color fundus imaging: The backbone of our journey in genotype-phenotype correlation. | Indian J Ophthalmol | 2024 | 38546475 | PubTator, text mining | PubMed |
| Cognitive decline, Aβ pathology, and blood-brain barrier function in aged 5xFAD mice. | Fluids Barriers CNS | 2024 | 38532486 | PubTator, text mining | PubMed |
| Genetics, Clinical Characteristics, and Natural History of PDE6B-Associated Retinal Dystrophy. | Am J Ophthalmol | 2024 | 38364953 | PubTator, text mining | PubMed |
| Acute tenosynovitis following an accidental injection of Bacille Calmette-Guérin (BCG) in a health care worker: A case report. | Infect Prev Pract | 2024 | 38292208 | PubTator, text mining | PubMed |
| Advanced Cellular Models for Rare Disease Study: Exploring Neural, Muscle and Skeletal Organoids. | Int J Mol Sci | 2024 | 38256087 | PubTator, text mining | PubMed |
| Whole genome sequencing enables new genetic diagnosis for inherited retinal diseases by identifying pathogenic variants. | NPJ Genom Med | 2024 | 38245557 | PubTator, text mining | PubMed |
| Highly efficient capture approach for the identification of diverse inherited retinal disorders. | NPJ Genom Med | 2024 | 38195571 | PubTator, text mining | PubMed |
| Continent-island boundary and environment-shaped evolution in the marine amphipod Ampithoe marcuzzii complex (Crustacea: Eumalacostraca: Ampithoidae). | Sci Rep | 2024 | 38182880 | PubTator, text mining | PubMed |
| Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38172098 | PubTator, text mining | PubMed |
| Reprogramming biocatalytic futile cycles through computational engineering of stereochemical promiscuity to create an amine racemase. | Nat Commun | 2024 | 38169460 | PubTator, text mining | PubMed |
| Dynamic monitoring of UBA1 somatic mutations in patients with relapsing polychondritis. | Orphanet J Rare Dis | 2024 | 38167209 | PubTator, text mining | PubMed |
| Probing the mechanism by which the retinal G protein transducin activates its biological effector PDE6. | J Biol Chem | 2024 | 38159849 | PubTator, text mining | PubMed |
| Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and Beyond. | Ophthalmol Ther | 2024 | 38113023 | PubTator, text mining | PubMed |
| Identification of Two Novel ANKRD11 Mutations: Highlighting Incomplete Penetrance in KBG Syndrome. | Ann Lab Med | 2024 | 37665295 | PubTator, text mining | PubMed |
| Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine. | Genes Dis | 2024 | 37588217 | PubTator, text mining | PubMed |
| RNA-Seq Analysis of Trans-Differentiated ARPE-19 Cells Transduced by AAV9-AIPL1 Vectors. | Int J Mol Sci | 2023 | 38203368 | PubTator, text mining | PubMed |
| AAV for Gene Therapy in Ocular Diseases: Progress and Prospects. | Research (Wash D C) | 2023 | 38188726 | PubTator, text mining | PubMed |
| Whole genome sequencing and comparative genomics of Mycobacterium orygis isolated from different animal hosts to identify specific diagnostic markers. | Front Cell Infect Microbiol | 2023 | 38188626 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5158/papers?page=4